|
|
|
|
Neopterin/Biopterin Profile – Urine
|
|
Overview
|
Clinician Info
|
CPT Codes
|
Kit Instructions
|
Sample Reports
|
Interpretive Guide
|
References
|
|
|
|
Neopterin/Biopterin Profile*
|
Oxidative Products of Tetrahydrobiopterin (BH4)
Neopterin and biopterin are by-products of the redox reactions involving tetrahydrobiopterin (BH4). BH4 functions as a cofactor for the enzymes responsible for the production of monoamine neurotransmitters (ephinepherine, norepinephrine, DOPA, serotonin), and as a cofactor in nitric oxide production. Low biopterin levels may reflect insufficient BH4 status. Restricted BH4 cofactor availability has been suggested as an etiologic factor in:
- Neurological Disease - Alzheimer's Disease, Parkinson's Disease, Autism, Depression, DOPA-responsive Dystonia
- Insulin Resistance
- Cardiovascular Disease
- Inborn-errors of metabolism: Phenylketonuria, Hyperphenylalaninemia
Neopterin is a marker of inflammation, allowing detection and monitoring of inflammatory processes. The origin of the inflammation may be the small intestine pathology that so often requires treatment in children with Autism Spectrum Disorders. Neopterin is elevated in:
- Infections
- Autoimmune diseases: Rheumatoid Arthritis, Systemic Lupus, and Atopic Asthma
- Malignant diseases
- Psychiatric disorders
- Sleep-disordered breathing
- Children with Autism Spectrum Disorders
Read the Neopterin and Biopterin White Paper for more information!
*This profile is not available in New York. |
|

Metametrix Neopterin/Biopterin Profile:
|
Clinician Info
| Test name: |
0088 - Neopterin/Biopterin Profile*
|
|
|
| Description: |
Neopterin and biopterin are by-products of the redox
reactions involving tetrahydrobiopterin (BH4). BH4 functions as a
cofactor for the enzymes responsible for the production of monoamine
neurotransmitters (epinephrine, norepinephrine, DOPA, serotonin),
and as a cofactor in nitric oxide production.1,2 Low biopterin levels
may reflect insufficient BH4 status.
1. Blau N TB, Cotton GH, Hyland K. Disorders of Tetrahydrobiopterin and Related Biogenic Amenes. Online Metabolic and Molecular Basis of Inherited Disease. 2005.
2. Werner-Felmayer G, Golderer G, Werner ER. Tetrahydrobiopterin biosynthesis, utilization and pharmacological effects. Curr Drug Metab. Apr 2002; 3(2):159-173.
|
|
|
| Method: |
LC/MS-MS, Spectrophotometry |
|
|
| Turnaround time: |
7-10 days, 9 days average |
|
|
|
Analytes:
|
Neopterin Biopterin Creatinine
*Not available in New York
|
|
CPT codes:
| 83789 x 2 |
- |
| LC/MS-MS, NES; quantitative:
|
|
|
| Neopterin/Biopterin* |
| 82570 |
- |
| Creatinine |
|
|
| |
|
|
| *Not reported in New York |
|
The PDF should now automatically load in another browser window.
If the PDF has not yet loaded, please click link below:
|
| |
 |
|
We're sorry, the page you've requested is unavailable. If you would like to notify our Web Development staff of this broken link, please email us at webdevelopment@metametrix.com. If you have any other questions, comments, or requests regarding this or any other information on our site, feel free to contact us through the Contact Us page.
Thank you,
Metametrix Clinical Laboratory |
|
|
|
|